LANDER; Cynthia

Patent Applications and Registrations

Patent applications and USPTO patent grants for LANDER; Cynthia.The latest application filed is for "inhibition of cardiac fibrosis in myocardial infarction".

Company Profile

8.8.22

LANDER; Cynthia - Mendham NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Inhibition Of Cardiac Fibrosis In Myocardial Infarction App 20200172574 - LANDER; Cynthia ; et al.	2020-06-04
Compositions and methods for preventing or treating diseases, conditions or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition Grant 10,562,947 - Lander , et al. Feb	2020-02-18
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition Grant 10,500,249 - Lander , et al. Dec	2019-12-10
Inhibition of cardiac fibrosis in myocardial infarction Grant 10,336,788 - Lander , et al.	2019-07-02
Immunomodulatory Effect Of Inhaled Kinase Inhibitor Peptides In Lung App 20190134153 - Lander; Cynthia	2019-05-09
Formulation Of Mk2 Inhibitor Peptides App 20190031730 - Lander; Cynthia ; et al.	2019-01-31
Compositions And Methods For Preventing Or Treating Diseases, Conditions, Or Processes Characterized By Aberrant Fibroblast Proliferation And Extracellular Matrix Deposition App 20190022169 - Lander; Cynthia ; et al.	2019-01-24
Use Of Mk2 Inhibitor Peptide-containing Compositions For Treating Non-small Cell Lung Cancer With Same App 20190022176 - Lander; Cynthia ; et al.	2019-01-24
Formulation of MK2 inhibitor peptides Grant 10,087,225 - Lander , et al. October 2, 2	2018-10-02
Compositions And Methods For Preventing Or Treating Diseases, Conditions Or Processes Characterized By Aberrant Fibroblast Proliferation And Extracellular Matrix Deposition App 20180194817 - Lander; Cynthia ; et al.	2018-07-12
Use of MKS inhibitor peptide-containing compositions for treating non-small cell lung cancer with same Grant 9,999,655 - Lander , et al. June 19, 2	2018-06-19
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition Grant 9,890,200 - Lander , et al. February 13, 2	2018-02-13
Treatment Of Drug Resistant Proliferative Diseases With Telomerase Mediated Telomere Altering Compounds App 20180036331 - Shay; Jerry ; et al.	2018-02-08
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition Grant 9,642,888 - Lander , et al. May 9, 2	2017-05-09
Use Of Mks Inhibitor Peptide-containing Compositions For Treating Non-small Cell Lung Cancer With Same App 20160263187 - Lander; Cynthia ; et al.	2016-09-15
Formulation Of Mk2 Inhibitor Peptides App 20160200782 - Lander; Cynthia ; et al.	2016-07-14
Compositions and Methods for Preventing or Treating Diseases, Conditions, or Processes Characterized by Aberrant Fibroblast Proliferation and Extracellular Matrix Deposition App 20160136234 - Lander; Cynthia ; et al.	2016-05-19
Inhibition Of Cardiac Fibrosis In Myocardial Infarction App 20150299264 - Lander; Cynthia ; et al.	2015-10-22
Compositions And Methods For Preventing Or Treating Chronic Lung Allograft Dysfunction (clad) And Idiopathic Pulmonary Fibrosis (ipf) App 20150258192 - Brophy; Colleen ; et al.	2015-09-17
Compositions And Methods For Preventing Or Treating Diseases, Conditions, Or Processes Characterized By Aberrant Fibroblast Proliferation And Extracellular Matrix Deposition App 20150064134 - Lander; Cynthia ; et al.	2015-03-05
Compositions and Methods for Treating Cutaneous Scarring App 20140072613 - Lander; Cynthia ; et al.	2014-03-13
Methods For Treating Or Preventing Vascular Graft Failure App 20130115256 - Lander; Cynthia ; et al.	2013-05-09
Compositions And Methods For Preventing Or Treating Diseases, Conditions, Or Processes Characterized By Aberrant Fibroblast Proliferation And Extracellular Matrix Deposition App 20120263680 - Lander; Cynthia ; et al.	2012-10-18
Methods for Treating or Preventing Vascular Graft Failure App 20110288036 - Lander; Cynthia ; et al.	2011-11-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.